Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: Clinical manifestations and outcomes between pediatric and adult patients.

Lee HY, Lu CY, Lee PI, Chen JM, Huang LM, Chang LY.

J Microbiol Immunol Infect. 2019 May 22. pii: S1684-1182(19)30051-9. doi: 10.1016/j.jmii.2019.05.003. [Epub ahead of print]

2.

Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals.

Li MC, Lee NY, Lee CC, Lee HC, Chang CM, Ko WC.

J Microbiol Immunol Infect. 2014 Feb;47(1):42-7. doi: 10.1016/j.jmii.2012.08.024. Epub 2012 Oct 11.

3.

CMV pneumonia in HIV-infected ventilated infants.

Goussard P, Kling S, Gie RP, Nel ED, Heyns L, Rossouw GJ, Janson JT.

Pediatr Pulmonol. 2010 Jul;45(7):650-5. doi: 10.1002/ppul.21228.

PMID:
20575098
4.

Cytomegaloviral or Pneumocystis Jiroveci Pneumonia Increases Mortality in Systemic Lupus Erythematosus Patients with Pulmonary Hemorrhage: Evidence from Bronchoalveolar Lavage Fluid.

Sun YS, Huang DF, Lin FC, Hsu CK, Sun IT, Chang SC, Tsai CY, Lai CC.

J Rheumatol. 2019 Mar;46(3):251-258. doi: 10.3899/jrheum.180104. Epub 2018 Dec 1.

PMID:
30504509
5.
6.

Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial.

Newberry L, O'Hare B, Kennedy N, Selman A, Omar S, Dawson P, Stevenson K, Nishihara Y, Lissauer S, Molyneux E.

Paediatr Int Child Health. 2017 May;37(2):121-128. doi: 10.1080/20469047.2016.1260891. Epub 2017 Feb 1.

PMID:
28145162
7.

Pneumocystis jiroveci pneumonia (PJP) in non-HIV immunocompromised individuals.

Schoovaerts K, Dirix L, Rutten A, Van Schaeren J, Van Herendael B, Van Grieken S, Heytens L.

Acta Clin Belg. 2017 Dec;72(6):413-416. doi: 10.1080/17843286.2017.1305136. Epub 2017 Mar 27.

PMID:
28346081
8.

Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.

Mecoli CA, Saylor D, Gelber AC, Christopher-Stine L.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):671-673. Epub 2017 Jan 27.

PMID:
28134084
9.

Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.

Basiaga ML, Ross ME, Gerber JS, Ogdie A.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):283-289. doi: 10.1093/jpids/pix052.

PMID:
28992298
10.
11.

Lethal Pneumocystis jiroveci pneumonia 24 Years After Kidney Transplantation.

Rezavand B, Hosseini MJ, Izadi M, Mahmoodzadeh Poornaki A, Sadraei J, Einollahi B, Rezaimanesh MR, Bagheri O, Abdi J.

Nephrourol Mon. 2014 Mar 9;6(2):e13605. doi: 10.5812/numonthly.13605. eCollection 2014 Mar. Erratum in: Nephrourol Mon. 2014 Jul;6(4):e19786.

12.

Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.

Avino LJ, Naylor SM, Roecker AM.

Ann Pharmacother. 2016 Aug;50(8):673-9. doi: 10.1177/1060028016650107. Epub 2016 May 30. Review.

PMID:
27242349
13.

Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered?

Okafor PN, Nunes DP, Farraye FA.

Inflamm Bowel Dis. 2013 Jul;19(8):1764-71. doi: 10.1097/MIB.0b013e318281f562. Review.

PMID:
23615530
14.

Risk factors for Pneumocystis jiroveci pneumonia in glomerulonephritis patients receiving immunosuppressants.

Yang CY, Yang AH, Yang WC, Lin CC.

Intern Med. 2012;51(20):2869-75. Epub 2012 Oct 15.

15.

Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.

Diri R, Anwer F, Yeager A, Krishnadasan R, McBride A.

Transpl Infect Dis. 2016 Feb;18(1):63-9. doi: 10.1111/tid.12486. Epub 2016 Jan 30.

PMID:
26606757
16.

Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients.

Ricciardi A, Gentilotti E, Coppola L, Maffongelli G, Cerva C, Malagnino V, Mari A, Di Veroli A, Berrilli F, Apice F, Toschi N, Di Cave D, Parisi SG, Andreoni M, Sarmati L.

PLoS One. 2017 May 15;12(5):e0176881. doi: 10.1371/journal.pone.0176881. eCollection 2017.

17.

Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation.

Lu YM, Lee YT, Chang HC, Yang HS, Chang CY, Huang CM, Wei J.

Transplant Proc. 2017 Oct;49(8):1893-1898. doi: 10.1016/j.transproceed.2017.04.020.

PMID:
28923644
18.

Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades.

García-Moreno J, Melendo-Pérez S, Martín-Gómez MT, Frick MA, Balcells-Ramírez J, Pujol-Jover M, Martín-Nalda A, Mendoza-Palomar N, Soler-Palacín P.

Enferm Infecc Microbiol Clin. 2019 Jul 1. pii: S0213-005X(19)30187-9. doi: 10.1016/j.eimc.2019.05.005. [Epub ahead of print] English, Spanish.

PMID:
31272810
19.

Pneumocystis jiroveci in HIV/AIDS patients: detection by FTA filter paper together with PCR in noninvasive induced sputum specimens.

Jaijakul S, Saksirisampant W, Prownebon J, Yenthakam S, Mungthin M, Leelayoova S, Nuchprayoon S.

J Med Assoc Thai. 2005 Sep;88 Suppl 4:S294-9.

PMID:
16623044
20.

Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease.

Okafor PN, Farraye FA, Okafor AT, Erim DO.

Dig Dis Sci. 2015 Dec;60(12):3743-55. doi: 10.1007/s10620-015-3796-4. Epub 2015 Jul 16.

PMID:
26177704

Supplemental Content

Support Center